JPS6342637B2 - - Google Patents
Info
- Publication number
- JPS6342637B2 JPS6342637B2 JP55151609A JP15160980A JPS6342637B2 JP S6342637 B2 JPS6342637 B2 JP S6342637B2 JP 55151609 A JP55151609 A JP 55151609A JP 15160980 A JP15160980 A JP 15160980A JP S6342637 B2 JPS6342637 B2 JP S6342637B2
- Authority
- JP
- Japan
- Prior art keywords
- arginyl
- amino
- alanyl
- methyl
- leucyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- FARHNJDDPBXWES-UHFFFAOYSA-N 3-amino-4-methylchromen-2-one hydrochloride Chemical compound CC1=C(C(OC2=C1C=CC=C2)=O)[NH3+].[Cl-] FARHNJDDPBXWES-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 102000004142 Trypsin Human genes 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KUZPZUOUPFQMLY-NSHDSACASA-N 2-[(4S)-4-amino-5-(3-amino-4-methyl-2-oxochromen-7-yl)-5-oxopentyl]guanidine Chemical compound N[C@@H](CCCNC(N)=N)C(=O)C1=CC=C2C(=C(C(OC2=C1)=O)N)C KUZPZUOUPFQMLY-NSHDSACASA-N 0.000 description 1
- YPLZVJKSYBUKBU-UHFFFAOYSA-N 3-amino-4-methylchromen-2-one Chemical compound C1=CC=CC2=C1OC(=O)C(N)=C2C YPLZVJKSYBUKBU-UHFFFAOYSA-N 0.000 description 1
- JBLCNYYEKMHEHD-UHFFFAOYSA-N 3-methylchromen-2-one;hydrochloride Chemical compound Cl.C1=CC=C2OC(=O)C(C)=CC2=C1 JBLCNYYEKMHEHD-UHFFFAOYSA-N 0.000 description 1
- PSGQCCSGKGJLRL-UHFFFAOYSA-N 4-methyl-2h-chromen-2-one Chemical compound C1=CC=CC2=C1OC(=O)C=C2C PSGQCCSGKGJLRL-UHFFFAOYSA-N 0.000 description 1
- -1 7-(leucyl-alanyl-arginyl)-4-methyl-coumarin Chemical compound 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- MDXGYYOJGPFFJL-QMMMGPOBSA-N N(alpha)-t-butoxycarbonyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)OC(C)(C)C MDXGYYOJGPFFJL-QMMMGPOBSA-N 0.000 description 1
- GSJNKKFGKIHNKV-UHFFFAOYSA-N NC1(CC(OC2=CC=CC=C12)=O)C Chemical compound NC1(CC(OC2=CC=CC=C12)=O)C GSJNKKFGKIHNKV-UHFFFAOYSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- GLNDAGDHSLMOKX-UHFFFAOYSA-N coumarin 120 Chemical compound C1=C(N)C=CC2=C1OC(=O)C=C2C GLNDAGDHSLMOKX-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- TYRGLVWXHJRKMT-QMMMGPOBSA-N n-benzyloxycarbonyl-l-serine-betalactone Chemical compound OC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-QMMMGPOBSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Description
【発明の詳細な説明】
本発明は式()で示される新規なペプチド誘
導体及び酸付加塩に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel peptide derivatives and acid addition salts represented by formula ().
本発明化合物1は酵素に対する基質として有用
な化合物である。 Compound 1 of the present invention is a compound useful as a substrate for enzymes.
従来酵素活性の測定には種々の方法が知られて
いるが、更に高感度かつ簡便に特定の酵素の活性
を測定する方法が望まれている。 Although various methods have been known for measuring enzyme activity, there is a need for a more sensitive and convenient method for measuring the activity of a specific enzyme.
本発明物質は種々の酵素によつて加水分解され
る基質として作用し、酵素の力価、純度等の高感
度な測定に有用な物質である。 The substance of the present invention acts as a substrate that is hydrolyzed by various enzymes, and is useful for highly sensitive measurement of enzyme titer, purity, etc.
本発明のペプチド誘導体は下記のようにして製
造することができる。N〓―保護―アラニンを常
法により活性エステルとなし、これと7―アルギ
ニル―アミノ―4―メチルクマリンと反応せしめ
ることにより7―(N〓―保護―アラニル―アル
ギニル)―4―メチル―クマリンが得られる。保
護基を脱離したのち、アミノ基を保護したロイシ
ンの活性エステルを反応させることにより7―
(N〓―保護―ロイシル―アラニル―アルギニル)
―4―メチル―クマリンが得られる。同様に保護
基を脱離させると7―(ロイシル―アラニル―ア
ルギニル)―4―メチル―クマリンが得られる。
本発明のペプチド誘導体を製造する際の反応は通
常用いられる方法でよい。例えば溶媒としてはジ
メチルホルムアミド(DMF)、ジメチルスルホキ
シド(DMSO)、水、あるいはこれらの混合物の
中で行なうのがよい。 The peptide derivative of the present invention can be produced as follows. By converting N〓-protected-alanine into an active ester by a conventional method and reacting it with 7-arginyl-amino-4-methylcoumarin, 7-(N〓-protected-alanyl-arginyl)-4-methyl-coumarin is obtained. is obtained. After removing the protecting group, 7-
(N〓-protected-leucyl-alanyl-arginyl)
-4-methyl-coumarin is obtained. Similarly, when the protecting group is removed, 7-(leucyl-alanyl-arginyl)-4-methyl-coumarin is obtained.
The reaction for producing the peptide derivative of the present invention may be carried out by a commonly used method. For example, the solvent may preferably be dimethylformamide (DMF), dimethylsulfoxide (DMSO), water, or a mixture thereof.
又、アミノ基成分と反応させるカルボキシル基
成分は活性エステルとして用いるのが有利であ
り、N―ヒドロキシスクシニルイミドエステルが
好適である。反応温度は室温程度でよい。反応終
了後反応混合物を濃縮乾固し、残留物をカラムク
ロマトグラフイーにより精製し、凍結乾燥する。
ここで得られた化合物の保護基は所望により、通
常の方法で脱離することができる。例えば第三級
ブチルオキシカルボニル基はトリフロロ酢酸、又
は塩酸―ジオキサン等通常用いられるもので脱離
できる。 Further, the carboxyl group component to be reacted with the amino group component is advantageously used as an active ester, and N-hydroxysuccinylimide ester is preferred. The reaction temperature may be around room temperature. After the reaction is completed, the reaction mixture is concentrated to dryness, and the residue is purified by column chromatography and freeze-dried.
The protective group of the compound obtained here can be removed by a conventional method, if desired. For example, a tertiary butyloxycarbonyl group can be removed using commonly used agents such as trifluoroacetic acid or hydrochloric acid-dioxane.
次に本発明を例示する。 Next, the present invention will be illustrated.
例
7―L―アルギニルアミノ―4―メチルクマリ
ン塩酸塩・1/2水和物754mgをDMF25mlと水25ml
に溶解しこの中にカルボベンゾキシ―L―アラニ
ンのN―ヒドロキシスクシニルイミドエステル
833mgを加え室温で一晩撹拌したのち濃縮乾固し
た。この残留物を溶媒としてクロロホルム/メチ
ルアルコール/酢酸(95/5/3〜90/20/5)
の混合溶媒を用いてシリカゲルカラムクロマトグ
ラフイーで精製(SiO2 50g)し、目的物を含む
フラクシヨンを集め、凍結乾燥することにより7
―(N〓―カルボベンゾキシ―L―アラニル―L
―アルギニル)アミノ―4―メチルクマリン塩酸
塩900mgを得た。Example 7-L-Arginylamino-4-methylcoumarin hydrochloride 1/2 hydrate 754 mg in DMF 25 ml and water 25 ml
N-hydroxysuccinylimide ester of carbobenzoxy-L-alanine is dissolved in
After adding 833 mg and stirring at room temperature overnight, the mixture was concentrated to dryness. Using this residue as a solvent, chloroform/methyl alcohol/acetic acid (95/5/3 to 90/20/5)
Purification was performed by silica gel column chromatography using a mixed solvent of
-(N〓-carbobenzoxy-L-alanyl-L
-Arginyl)amino-4-methylcoumarin hydrochloride (900 mg) was obtained.
融点約182℃(分解点)。Melting point: approximately 182℃ (decomposition point).
IR、3200,1715,1690,1660cm-1。IR, 3200, 1715, 1690, 1660 cm -1 .
ここで得られた7―(N〓―カルボベンゾキシ
―L―アラニル―L―アルギニル)アミノ―4―
メチルクマリン塩酸塩650mgをメタノール80mlに
けんだくし、10%パラジウム炭素150mgを加え水
素ガスを3時間通導する。反応後ろ過してパラジ
ウム炭素を除き、母液を減圧濃縮し、残渣に無水
エーテルを加えることにより7―(L―アラニル
―L―アルギニル)アミノ―4―メチルクマリン
塩酸塩440mgを得た。融点約98℃(分解点)。 7-(N〓-carbobenzoxy-L-alanyl-L-arginyl)amino-4- obtained here
650 mg of methylcoumarin hydrochloride was suspended in 80 ml of methanol, 150 mg of 10% palladium on carbon was added, and hydrogen gas was passed through the mixture for 3 hours. After the reaction, palladium on carbon was removed by filtration, the mother liquor was concentrated under reduced pressure, and anhydrous ether was added to the residue to obtain 440 mg of 7-(L-alanyl-L-arginyl)amino-4-methylcoumarin hydrochloride. Melting point: approximately 98℃ (decomposition point).
IR 3300,1670,1610cm-1。IR 3300, 1670, 1610cm -1 .
ここで得た7―(L―アラニル―L―アルギニ
ル)アミノ―4―メチルクマリン塩酸塩400mgを
DMF20mlに溶解し、t―ブチルオキシカルボニ
ル―L―ロイシンのN―ヒドロキシスクシニルイ
ミドエステル400mgを加え、室温で一晩撹拌する。
反応液を濃縮乾固し残渣を溶媒としてクロロホル
ム/メチルアルコール/酢酸(80/20/4)の混
合溶媒を用いて、シリカゲルカラムクロマトグラ
フイーで精製(SiO2 30g)し、7―(N〓―t―
ブチルオキシカルボニル―L―ロイシル―L―ア
ラニル―L―アルギニル)アミノ―4―メチルク
マリン塩酸塩270mgを得た。 400 mg of 7-(L-alanyl-L-arginyl)amino-4-methylcoumarin hydrochloride obtained here was added to
Dissolve in 20 ml of DMF, add 400 mg of N-hydroxysuccinylimide ester of t-butyloxycarbonyl-L-leucine, and stir overnight at room temperature.
The reaction solution was concentrated to dryness, and the residue was purified by silica gel column chromatography (30 g of SiO 2 ) using a mixed solvent of chloroform/methyl alcohol/acetic acid (80/20/4) as a solvent. -t-
270 mg of butyloxycarbonyl-L-leucyl-L-alanyl-L-arginyl)amino-4-methylcoumarin hydrochloride was obtained.
融点約70℃(分解点)。Melting point: approximately 70℃ (decomposition point).
IR 3300,1650,1610cm-1。IR 3300, 1650, 1610cm -1 .
7―(N〓―t―ブチルオキシカルボニル―L
―ロイシル―L―アラニル―L―アルギニル)ア
ミノ―4―メチルクマリン塩酸塩200mgをジオキ
サン3mlにけんだくし、9.8%塩酸―ジオキサン
溶液5.0gを加え室温で3時間30分撹拌する。反
応液にメチルアルコール5mlを加えさらに1時間
撹拌したのち、低温で溶媒を留去し、残渣に無水
エーテルを加えて析出する白色粉末、7―(L―
ロイシル―L―アラニル―L―アルギニル)アミ
ノ―4―メチルクマリン塩酸塩を集める。140mg。 7-(N〓-t-butyloxycarbonyl-L
200 mg of -leucyl-L-alanyl-L-arginyl)amino-4-methylcoumarin hydrochloride is suspended in 3 ml of dioxane, 5.0 g of 9.8% hydrochloric acid-dioxane solution is added, and the mixture is stirred at room temperature for 3 hours and 30 minutes. After adding 5 ml of methyl alcohol to the reaction solution and stirring for another hour, the solvent was distilled off at a low temperature, and anhydrous ether was added to the residue to precipitate a white powder, 7-(L-
Leucyl-L-alanyl-L-arginyl)amino-4-methylcoumarin hydrochloride is collected. 140mg.
融点約116℃(分解点)。Melting point: approximately 116℃ (decomposition point).
IR 3350,1650,1615cm-1。IR 3350, 1650, 1615cm -1 .
7―(t―ブチルオキシカルボニル―L―ロイ
シル―L―アラニル―L―アルギニル)アミノ―
4―メチル―クマリンを基質としたトリプシンの
活性測定法
10mM塩化カルシウムを含む50mMトリス塩酸
緩衝液(PH8.0)に7―(t―ブチルオキシカル
ボニル―L―ロイシル―L―アラニル―L―アル
ギニル)アミノ―4―メチル―クマリンを
0.1mMの濃度に溶かしたものを基質液とする。
この基質液2mlに各種濃度のトリプシン液0.1ml
を加え37℃で30分間インキユベートしたのち17%
酢酸液2mlを加える。酵素により水解されて遊離
した7―アミノ―4―メチル―クマリンを励起波
長380nm、螢光波長460nmにおける螢光強度とし
て測定する。この遊離した4―アミノ―4―メチ
ル―クマリン(AMC)が酵素の活性度に相当す
る。 7-(t-butyloxycarbonyl-L-leucyl-L-alanyl-L-arginyl)amino-
Trypsin activity measurement method using 4-methyl-coumarin as a substrate 7-(t-butyloxycarbonyl-L-leucyl-L-alanyl-L-arginyl ) Amino-4-methyl-coumarin
Use the solution dissolved to a concentration of 0.1mM as the substrate solution.
2 ml of this substrate solution and 0.1 ml of trypsin solution of various concentrations.
After adding and incubating at 37℃ for 30 minutes, 17%
Add 2 ml of acetic acid solution. The 7-amino-4-methyl-coumarin liberated by hydrolysis by the enzyme is measured as the fluorescence intensity at an excitation wavelength of 380 nm and a fluorescence wavelength of 460 nm. This released 4-amino-4-methyl-coumarin (AMC) corresponds to the activity of the enzyme.
この方法によつて測定したトリプシンの各濃度
段階における結果を図に示す。図中で縦軸は30分
間でトリプシンによつて遊離したAMCをnmole
で表わし、横軸はトリプシンをngで表わしてあ
る。 The results at each concentration level of trypsin measured by this method are shown in the figure. In the figure, the vertical axis represents nmole of AMC released by trypsin in 30 minutes.
The horizontal axis shows trypsin in ng.
図は本発明化合物を用いた酵素の活性の測定結
果を表わす。
The figure shows the results of measuring enzyme activity using the compound of the present invention.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55151609A JPS5775956A (en) | 1980-10-29 | 1980-10-29 | Peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55151609A JPS5775956A (en) | 1980-10-29 | 1980-10-29 | Peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5775956A JPS5775956A (en) | 1982-05-12 |
JPS6342637B2 true JPS6342637B2 (en) | 1988-08-24 |
Family
ID=15522267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP55151609A Granted JPS5775956A (en) | 1980-10-29 | 1980-10-29 | Peptide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5775956A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0888459A1 (en) * | 1996-02-02 | 1999-01-07 | Stichting Onderzoeksbeleid Cardiopulmonale Chirurgie | Measurement of complement activation by biomaterials by means of complement convertase cleavage of peptide substrates |
-
1980
- 1980-10-29 JP JP55151609A patent/JPS5775956A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5775956A (en) | 1982-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4237047A (en) | Peptide derivative | |
JPS6126558B2 (en) | ||
JP3166125B2 (en) | Production method of indole derivatives | |
JPS6342637B2 (en) | ||
JPS6150941B2 (en) | ||
JPS6121640B2 (en) | ||
CA1331602C (en) | Preparation process of acemetacin | |
JP3716376B2 (en) | Optical resolving agent and method for producing optically active 3-aminopyrrolidine derivative using the same | |
US5977380A (en) | Process for preparing N-[1- (S)-ethoxycarbonyl-3- phenylpropyl]-L-alanine derivatives | |
HU181503B (en) | Process for producing 3,3-ethylenedioxy-4,5-seco-19-nor-androst-9-ene-5,17-dione | |
JPS6130559B2 (en) | ||
JPS59112952A (en) | Peptide derivative | |
JP2909145B2 (en) | Preparation of β-lactamase inhibitors | |
US5003064A (en) | Method for the preparation of monohydrate | |
JPS6338355B2 (en) | ||
JPS626560B2 (en) | ||
JPH0363560B2 (en) | ||
KR930007419B1 (en) | Process for preparing cephalosporin derivatives | |
JPS6027675B2 (en) | 7-Arginylamino-4-methylcoumarin | |
JPS63139184A (en) | Production of 6-(d(-)-alpha-(4-ethyl-2, 3-dioxopyperadine-1-ylcarbonylamino)-alpha-phenyl- acetamide)-penicillanic acid | |
JPS63500721A (en) | New manufacturing method for chemical compounds | |
JPS5842862B2 (en) | peptide derivative | |
KR100208297B1 (en) | Novel process for preparing cephem derivatives | |
JP3005072B2 (en) | Preparation of cephalosporin derivatives | |
JPS6337094B2 (en) |